LYONS GARY A
Director · 5 filings · Latest: Aug 17, 2026
NEUROCRINE BIOSCIENCES INC
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | LYONS GARY A | Director | Aug 18, 2026 | Sale | $63.37 | 5,000 | $316.9K | 61,500 | |
TVTX | LYONS GARY A | Director | Aug 18, 2026 | Option Exercise | $17.44 | 5,000 | $87.2K | 66,500 | |
TVTX | LYONS GARY A | Director | Aug 17, 2026 | Sale | $63.20 | 5,000 | $316.0K | 61,500 | |
TVTX | LYONS GARY A | Director | Aug 17, 2026 | Option Exercise | $17.44 | 5,000 | $87.2K | 66,500 | |
TVTX | GARY LYONS | — | Aug 18, 2026 | Proposed Sale | $63.53 | 5,000 | $317.6K | — | |
TVTX | GARY A LYONS | — | Aug 17, 2026 | Proposed Sale | $62.14 | 5,000 | $310.7K | — | |
NBIX | LYONS GARY A | Director | May 21, 2026 | Option Exercise | $0.00 | 1,659 | — | 122,141 | |
TVTX | LYONS GARY A | Director | Apr 14, 2026 | Sale | $41.07 | 8,000 | $328.6K | 57,500 | |
TVTX | LYONS GARY A | Director | Apr 14, 2026 | Option Exercise | $16.33 | 8,000 | $130.6K | 65,500 | |
TVTX | GARY A LYONS | — | Apr 14, 2026 | Proposed Sale | $30.70 | 8,000 | $245.6K | — | |
NBIX | GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012 | — | Dec 3, 2025 | Proposed Sale | $152.48 | 15,000 | $2.3M | — | |
TVTX | GARY A LYONS | — | Oct 4, 2024 | Proposed Sale | $13.65 | 40,000 | $546.0K | — |